| Jan'20 | Jan'19 | Jan'18 | Jan'17 | |||
|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||
Net loss | ||||||
-125,656 | -154,309 | -176,562 | -183,120 | |||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation and amortization | ||||||
6,917 | 8,787 | 8,131 | 4,895 | |||
Amortization of intangible assets | ||||||
- | - | - | 304 | |||
Amortization of contract acquisition costs | ||||||
11,777 | 8,200 | 9,000 | 7,782 | |||
Stock-based compensation expense | ||||||
23,847 | 21,801 | 9,370 | 9,343 | |||
Other, net | ||||||
-1,959 | 1,276 | -174 | - | |||
Reversal of contingent tax-related accrual | ||||||
- | - | - | 0 | |||
Capitalized interest | ||||||
- | - | - | 0 | |||
Remeasurement of warrant liability | ||||||
- | - | - | 0 | |||
Change in operating assets and liabilities: | ||||||
Accounts receivable, net | ||||||
-454 | 12,937 | 13,186 | 2,802 | |||
Contract acquisition costs | ||||||
13,178 | 15,677 | 17,160 | 11,742 | |||
Prepaid expenses and other | ||||||
1,739 | 4,824 | 1,610 | 826 | |||
Accounts payable | ||||||
-292 | -8,651 | 3,250 | 4,537 | |||
Accrued expenses and other liabilities | ||||||
-150 | 4,605 | 8,902 | 9,613 | |||
Deferred revenue | ||||||
15,842 | 22,946 | 21,020 | 17,872 | |||
Net cash used in operating activities | ||||||
-80,219 | -131,367 | -148,657 | -144,144 | |||
Cash flows from investing activities | ||||||
Purchases of property and equipment | ||||||
6,466 | 6,373 | 7,281 | 11,644 | |||
Purchases of securities available for sale | ||||||
102,084 | 0 | 0 | - | |||
Proceeds from maturities of securities available for sale | ||||||
84,800 | 0 | 0 | - | |||
Purchases of intangible assets | ||||||
65 | 1,603 | 315 | 0 | |||
Issuance of note receivable | ||||||
- | - | - | 500 | |||
Net cash used in investing activities | ||||||
-23,815 | -7,976 | -7,596 | -12,144 | |||
Cash flows from financing activities | ||||||
Proceeds from initial public offering, net of underwriting discounts and commissions | ||||||
0 | 206,627 | 0 | 0 | |||
Payments of costs related to initial public offering | ||||||
0 | 4,053 | 38 | 0 | |||
Proceeds from issuance of convertible preferred stock, net of issuance costs | ||||||
0 | -87 | 99,058 | 4,060 | |||
Proceeds from shares issued in connection with employee stock purchase plan | ||||||
7,812 | 0 | 0 | - | |||
Shares repurchased for tax withholdings on vesting of restricted stock | ||||||
1,428 | 0 | 0 | - | |||
Debt proceeds, net of issuance costs | ||||||
0 | 49,642 | 48,900 | 112 | |||
Proceeds from exercise of stock options | ||||||
1,600 | 2,250 | 1,338 | 748 | |||
Repurchases of common stock | ||||||
0 | 0 | 121 | 0 | |||
Principal payments on capital lease obligations | ||||||
0 | 44 | 37 | 42 | |||
Net cash provided by financing activities | ||||||
7,984 | 254,335 | 149,100 | -3,466 | |||
Effect of exchange rate changes on cash and cash equivalents | ||||||
-80 | 9 | 141 | 118 | |||
Net (decrease) increase in cash and cash equivalents | ||||||
-96,130 | 115,001 | -7,012 | -159,636 | |||
Supplemental disclosures of cash flow information | ||||||
Cash paid for income taxes | ||||||
365 | 822 | 499 | 212 | |||
Cash paid for interest | ||||||
9,083 | 6,903 | 314 | 26 | |||
Non-cash investing and financing activities | ||||||
Stock-based compensation capitalized as internal-use software | ||||||
480 | 528 | 0 | 0 | |||
Debt issuance costs in accounts payable, accrued liabilities and other liabilities, noncurrent | ||||||
0 | 1,993 | 2,726 | 0 | |||
Deferred initial public offering costs in accounts payable and accrued liabilities | ||||||
0 | 0 | 1,675 | 0 | |||
Issuance of warrants in connection with credit facility | ||||||
0 | 673 | 257 | 0 | |||
Convertible preferred stock issuance costs in accounts payable and accrued liabilities | ||||||
0 | 0 | 87 | 0 | |||
Conversion of convertible preferred stock to common stock | ||||||
0 | 693,158 | 0 | 0 | |||